Quantification of Free Immunoglobulin Light Chains in Urine

Background The serum-free immunoglobulin light chain assay has been recommended as a screening test for monoclonal gammopathy. We evaluated the usefulness of urine free immunoglobulin light concentration for selection of specimens for immunofixation electrophoresis.Methods Using kits from The Binding Site for Freelite (R), we validated examination of urine for measuring free ? and ? light chains. The results of urine free light chain concentrations were evaluated to ascertain if the results could be used to reduce the number of specimens requiring urine protein immunofixation electrophoresis.Results In the 515 specimens examined, there was no evidence of monoclonal gammopathy or history of monoclonal gammopathy in 331. Monoclonal ? or ? light chains were detectable in 42 and 30 specimens, respectively. There was history of ? or ? chain associated monoclonal gammopathy in 62 and 50 patients, respectively. In the 38 monoclonal ? positive urine specimens, with light chain data, ?/? ratio was >5.83 in all specimens. In 27 specimens positive for monoclonal ? light chains, with light chain data, the urine ?/? ratio was > 0.17 in 24 of 27 specimens and > 0.041 in all specimens. In patients without monoclonal gammopathy all specimens had a ?/? ratio of >5.83 or ?/? ratio >0.17.Conclusions The Freelite (R) assay from The Binding Site is suitable for quantification of free light chains in urine. In patients with known history of monoclonal gammopathy, urine immunofixation electrophoresis may be omitted in specimens with ?/? ratio of <5.83 for ? associated lesions and ?/? ratio of <0.041 for ? associated lesions. However, the results do not support using this test for first-time urine testing for monoclonal light chains as it is not predictive of positive result, nor does it exclude a monoclonal light chain in urine.